Biologic drugs that modulate the immune system have revolutionized the therapeutic landscape for several selected cancer types. A new study reports an image-based assay system to monitor cell–cell interactions, identifying small-molecule compounds with immunomodulatory capacity.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Sharma, P. & Allison, J.P. Cell 161, 205–214 (2015).
Vladimer, G.I. et al. Nat. Chem. Biol. 10.1038/nchembio.2360 (2017).
Murphy, A.G. & Zheng, L. Hum. Vaccin. Immunother. 11, 2463–2468 (2015).
Batista, F.D. & Dustin, M.L. Immunol. Rev. 251, 7–12 (2013).
Zanella, F., Lorens, J.B. & Link, W. Trends Biotechnol. 28, 237–245 (2010).
Shaw, A.T., Yasothan, U. & Kirkpatrick, P. Nat. Rev. Drug Discov. 10, 897–898 (2011).
Hoos, A. Nat. Rev. Drug Discov. 15, 235–247 (2016).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing financial interests.
Rights and permissions
About this article
Cite this article
Link, W. Mind the immuno-connection gap. Nat Chem Biol 13, 572–573 (2017). https://doi.org/10.1038/nchembio.2373
Published:
Issue Date:
DOI: https://doi.org/10.1038/nchembio.2373